Bio-Path Holdings Inc.

(BPTH) Trade

By |

Profile

Bio-Path Holdings Inc is a United States based clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of a Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and in combination with decitabine. The other drug candidates of the company are BP1002 and BP1003.

Contact Information

Website: www.biopathholdings.com
Email: dmorris@biopathholdings.com
Main Phone: +1 832 742-1357
Address: 4710 Bellaire Boulevard
Address 2: Suite 210
State: TX
City / Town: Bellaire
Country: USA
Postal Code: 77401

Issuer Information

Exchange: NSC
CEO: Peter H. Nielsen
Employees: 8
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Bio-Path Holdings Inc is a United States based clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of a Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and in combination with decitabine. The other drug candidates of the company are BP1002 and BP1003.

Contact Information

Website: www.biopathholdings.com
Email: dmorris@biopathholdings.com
Main Phone: +1 832 742-1357
Address: 4710 Bellaire Boulevard
Address 2: Suite 210
State: TX
City / Town: Bellaire
Country: USA
Postal Code: 77401

Issuer Information

Exchange: NSC
CEO: Peter H. Nielsen
Employees: 8
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 14.32 $ 0.30 (2.14%)
Last Price 14.32 Change $ 0.30 Change % 2.14 Tick N/A
Bid 14.21 Bid Size 100.00 Ask 14.33 Ask Size 1,000.00
Open 14.02 High 14.50 Low 13.70 Prev Close 14.02
Last Trade Volume 40,911 52 Wk Hi 73.52 52 Wk Low 1.61
Market Cap 40.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 2,831,356.00 EPS (TTM) -11.87 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 7
Number of Buys 5 7
Number of Sells 0 0
Net Activity 207500 257500
Last 10 Buys Shares
Michael J. Garrison 1,000
Michael J. Garrison 1,000
Michael J. Garrison 1,000
Michael J. Garrison 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 20 20 20 20
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 11/13/17 11/13/17 11/13/17 11/13/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1